Top

Reactions Weekly

Published in:

01-09-2011 | Case report

Bevacizumab/irinotecan

Interstitial pneumonitis: case report

Published in: Reactions Weekly | Issue 1/2011

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:

death
life-threatening
hospitalisation
disability
congenital anomaly
requires intervention to prevent permanent impairment or damage

…

Tamura J, Nakauchi M, Nakayama Y, Kitaguchi K, Sakikubo M, Ura K, Taira K, Ohe H, Yoshikawa A, Ishigami S-I, Baba N.A case of interstitial pneumonitis induced by FOLFIRI+bevacizumab combination therapy for liver and lung metastasis of colon cancer. Gan to Kagaku Ryoho 36: 2665-2668, No. 13, Dec 2009 - Japan

Title: Bevacizumab/irinotecan
Interstitial pneumonitis: case report
Publication date: 01-09-2011
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2011
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201113670-00029

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bevacizumab/irinotecan

Interstitial pneumonitis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2011

Antineoplastics

Caffeine/ergotamine/erythromycin interaction

Fentanyl/morphine/ropivacaine

Valproic acid

Immunosuppressants

Everolimus